PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma
Article in Cancer Letters (May 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer
Article in Biochemical Genetics (May 2024)
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling
Article in International Journal of Oncology (June 2023)